NASDAQ
Immune Therapeutics, Inc. (IMUN) has a fcf yield of -4.97% as of Friday, May 29, 2026. This represents a 77.88% increase compared to its 12-month average of -22.46%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.